Genmab AS Financials
| GMAB Stock | DKK 1,618 19.00 1.16% |
Genmab |
Understanding current and past Genmab AS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genmab AS's financial statements are interrelated, with each one affecting the others. For example, an increase in Genmab AS's assets may result in an increase in income on the income statement.
Genmab AS Stock Summary
Genmab AS competes with Ambu AS, DSV Panalpina, Bavarian Nordic, GN Store, and FLSmidth. Genmab AS develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. Genmab AS was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab AS is traded on Copenhagen Stock Exchange in Denmark.| Foreign Associate | USA |
| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0010272202 |
| Business Address | Kalvebod Brygge 43, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.genmab.com |
| Phone | (45) 70 20 27 29 |
| Currency | DKK - Danish Krone |
You should never invest in Genmab AS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genmab Stock, because this is throwing your money away. Analyzing the key information contained in Genmab AS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genmab AS Key Financial Ratios
Genmab AS's financial ratios allow both analysts and investors to convert raw data from Genmab AS's financial statements into concise, actionable information that can be used to evaluate the performance of Genmab AS over time and compare it to other companies across industries.| Return On Equity | 0.24 | |||
| Return On Asset | 0.1 | |||
| Target Price | 3239.73 | |||
| Beta | 0.67 |
Genmab Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genmab AS's current stock value. Our valuation model uses many indicators to compare Genmab AS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genmab AS competition to find correlations between indicators driving Genmab AS's intrinsic value. More Info.Genmab AS is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genmab AS is roughly 2.29 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genmab AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genmab AS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Genmab AS Systematic Risk
Genmab AS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genmab AS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Genmab AS correlated with the market. If Beta is less than 0 Genmab AS generally moves in the opposite direction as compared to the market. If Genmab AS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genmab AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genmab AS is generally in the same direction as the market. If Beta > 1 Genmab AS moves generally in the same direction as, but more than the movement of the benchmark.
Genmab AS February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genmab AS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genmab AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genmab AS based on widely used predictive technical indicators. In general, we focus on analyzing Genmab Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genmab AS's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.77 | |||
| Information Ratio | 0.085 | |||
| Maximum Drawdown | 13.56 | |||
| Value At Risk | (3.12) | |||
| Potential Upside | 2.58 |
Additional Information and Resources on Investing in Genmab Stock
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.